Tech selloff deepens as Nvidia earnings and AI financing fears loom
Market & SentimentA broad risk-off session: the Nasdaq 100 fell 2.67% and the S&P 500 1.91%, while the Dow held up better at -1.43%. Breadth was weak, with 353 decliners against 140 advancers, though 63.8% of stocks remain above their 50-day average. The AI trade led the retreat ahead of Nvidia's earnings and Anthropic's IPO, with defensive names attracting bids.
Sectors & StocksCommunication services (-3.22%) and information technology (-3.0%) led losses; consumer staples (+0.32%) and utilities (+0.11%) were the only gainers. Sandisk fell 8.58% and Micron 7.62% after a judge let a DRAM supply lawsuit proceed; Marvell lost 7.27% on AI de-risking and dilution from its Lumentum deal. Robinhood dropped 7.45% as crypto weakened. Starbucks rose 2.14% on rotation into defensives.
Rates, FX & CryptoThe 2-year yield fell 5bp to 4.83% and the 10-year 3bp to 5.12%, leaving the 2s10s spread at 29bp; the 3-month bill rose 2bp. The dollar firmed, with EUR/USD down 0.34% and USD/CNY 0.08% lower. Bitcoin slipped 0.6% to about $64,800 after a weekend liquidation cascade, and ether fell 0.47%.
Earnings & AnnouncementsTyson Foods reported FY2026 revenue of $56.42 billion and a fourth-quarter loss, yet its shares jumped as results topped views despite beef weakness. J&J agreed to buy Ollin Biosciences for up to $3.3 billion, adding a Phase 3 retinal antibody. Eli Lilly will acquire Calytrix Bio for up to $1.5 billion. No FinDog view changes today.
- Nvidia and Disney earnings; Home Depot and Target results
- Anthropic IPO pricing and AI trade reaction
- Fed speakers and inflation commentary
- Oil and crypto moves after recent volatility
- Equities fell as investors trimmed AI exposure before two pivotal events for the trade, with Nvidia's results and Anthropic's listing setting the tone for the week.
- Nvidia shares declined ahead of Tuesday's report, with interim CEO Colette Kress facing her first earnings test and reports that Jensen Huang could return as CEO.
- Google is purchasing 135 million Anthropic shares alongside the IPO, deepening a stake worth well over $100 billion at the midpoint price.
- Microsoft is one of seven cornerstone buyers in Anthropic's IPO placement, a day before its largest annual product event opens in San Francisco.
- The deal adds OLN324, a Phase 3 bispecific antibody targeting two drivers of retinal disease, expanding J&J's ophthalmology pipeline.
- Lilly agreed to buy privately held Calytrix Bio for up to $1.5 billion in cash, its second blood cancer acquisition this year.
- A federal judge rejected Micron, Samsung and SK hynix's bid to dismiss claims they cut conventional DRAM output to lift prices.
- The KC Fed president said the central bank still has work to do on inflation, a reminder that rate-cut expectations remain sensitive to price data.Reuters11-15 18:43 UTC
- Oil declined as recovering Middle East exports and forecasts of a fourth-quarter surplus weighed on prices.CNBC11-16 16:06 UTC
- Bitcoin's weakness pushed it below key technical support, triggering long liquidations over the weekend before a slight rebound.
Stories are selected and summarized by AI from the day's news coverage. Click a headline to read the original. Not investment advice.